Amyloidosis Bibliography of free accessible medical and biological reviews

Nr.	Year OPEN	Title	rate good	rate bad	no link	Citation
1	2006	Amyloidosis and the heart: a comprehensive review.	+	-	nl	Arch Intern Med 166(17):1805-13 (2006) Shah KB
2	2004	The systemic amyloidoses: clearer understanding of the molecular mechanisms offers hope for more effective therapies.	+	-	nl	J Intern Med 255(2):159-78 (2004) Merlini G
3	2004	Diagnostic and therapeutic approach of systemic amyloidosis.	+	-	nl	Neth J Med 62(4):121-8 (2004) Hazenberg BP
4	2004	Therapeutic options in systemic AL amyloidosis.	+	-	nl	Neth J Med 62(4):106-13 (2004) van Gameren II
5	2002	Beta-amyloid catabolism: roles for neprilysin (NEP) and other metallopeptidases?	+	-	nl	J Neurochem 81(1):1-8 (2002)
6	2008	Preventing beta-amyloid fibrillization and deposition: beta-sheet breakers and pathological chaperone inhibitors.	+	-	nl	BMC Neurosci 9 Suppl 2():S5 (2008) Wisniewski T
7	2008	Selective amyloid-beta lowering agents.	+	-	nl	BMC Neurosci 9 Suppl 2():S4 (2008) Wolfe MS
8	1993	Cardiac amyloidosis: a review and report of a new transthyretin (prealbumin) variant.	+	-	nl	Br Heart J 70(2):111-5 (1993)
9	2006	C-reactive protein (CRP)-lowering agents.	+	-	nl	Cardiovasc Drug Rev 24(1):33-50 (2006) Prasad K
10	2003	Nodular amyloidosis: review and long-term follow-up of 16 cases.	+	-	nl	Arch Dermatol 139(9):1157-9 (2003) Moon AO
11	2005	Primary, systemic amyloidosis and the dermatologist: where classic skin lesions may provide the clue for early diagnosis.	+	-	nl	Dermatol Online J 11(1):5 (2005) Silverstein SR
12	2001	3D domain swapping, protein oligomerization, and amyloid formation.	+	-	nl	Acta Biochim Pol 48(4):807-27 (2001)
13	2008	Potential roles of abundant extracellular chaperones in the control of amyloid formation and toxicity.	+	-	nl	Mol Biosyst 4(1):42-52 (2008) Wilson MR
14	2001	Pathogenesis, diagnosis and treatment of systemic amyloidosis.	+	-	nl	Philos Trans R Soc Lond B Biol Sci 356(1406):203-10; discussion 210-1 (2001)
15	2001	The structural basis of protein folding and its links with human disease.	+	-	nl	Philos Trans R Soc Lond B Biol Sci 356(1406):133-45 (2001)
16	2009	Mechanism of amyloidogenesis: nucleation-dependent fibrillation versus double-concerted fibrillation.	+	-	nl	BMB Rep 42(9):541-51 (2009) Bhak G
17	2005	Structure of beta-amyloid fibrils and its relevance to their neurotoxicity: implications for the pathogenesis of Alzheimer's disease.	+	-	nl	J Biosci Bioeng 99(5):437-47 (2005) Irie K
18	1985	Amyloid arthropathy.	+	-	nl	Ann Rheum Dis 44(11):727-8 (1985)
19	1991	Musculoskeletal manifestations of amyloidosis. A review of 83 patients on haemodialysis for at least 10 years.	+	-	nl	J Bone Joint Surg Br 73(2):271-6 (1991)
20	2008	Review article: gastrointestinal amyloidosis - clinical features, diagnosis and therapy.	+	-	nl	Aliment Pharmacol Ther 27(11):1006-16 (2008) Petre S
21	2008	Amyloidosis: is a cure possible?	+	-	nl	Ann Oncol 19 Suppl 4():iv63-6 (2008) Merlini G
22	2005	Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004.	+	-	nl	Am J Hematol 79(4):319-28 (2005) Gertz MA
23	2002	Amyloid-fibril formation. Proposed mechanisms and relevance to conformational disease.	+	-	nl	Eur J Biochem 269(14):3362-71 (2002)
24	2005	Mechanisms of amyloid fibril self-assembly and inhibition. Model short peptides as a key research tool.	+	-	nl	FEBS J 272(23):5971-8 (2005) Gazit E
25	2005	The Yin and Yang of protein folding.	+	-	nl	FEBS J 272(23):5962-70 (2005) Jahn TR
26	2005	Structures for amyloid fibrils.	+	-	nl	FEBS J 272(23):5950-61 (2005) Makin OS
27	2005	Aspects on human amyloid forms and their fibril polypeptides.	+	-	nl	FEBS J 272(23):5942-9 (2005) Westermark P
28	2009	Glimpses of the molecular mechanisms of beta2-microglobulin fibril formation in vitro: aggregation on a complex energy landscape.	+	-	nl	FEBS Lett 583(16):2623-9 (2009) Platt GW
29	2008	Structural classification of toxic amyloid oligomers.	+	-	nl	J Biol Chem 283(44):29639-43 (2008) Glabe CG
30	2008	The AbetaCs of Abeta-cleaving proteases.	+	-	nl	J Biol Chem 283(44):29645-9 (2008) Leissring MA
31	2008	The role of amyloid precursor protein processing by BACE1, the beta-secretase, in Alzheimer disease pathophysiology.	+	-	nl	J Biol Chem 283(44):29621-5 (2008) Cole SL
32	2008	Amyloid precursor protein trafficking, processing, and function.	+	-	nl	J Biol Chem 283(44):29615-9 (2008) Thinakaran G
33	2009	Structural polymorphism of Alzheimer Abeta and other amyloid fibrils.	+	-	nl	Prion 3(2):89-93 (2009) Fandrich M
34	2009	The multiple mechanisms of amyloid deposition: the role of parkin.	+	-	nl	Prion 3(1):5-11 (2009) Mena MA
35	2008	Amyloid fibrils: abnormal protein assembly.	+	-	nl	Prion 2(3):112-7 (2008) Rambaran RN
36	2007	Computational simulations of the early steps of protein aggregation.	+	-	nl	Prion 1(1):3-8 (2007) Wei G
37	2007	Hacking the code of amyloid formation: the amyloid stretch hypothesis.	+	-	nl	Prion 1(1):9-14 (2007) Pastor MT
38	2004	Unzipping the mysteries of amyloid fiber formation.	+	-	nl	Proc Natl Acad Sci U S A 101(13):4335-6 (2004) Miranker AD
39	2004	Polychlorinated biphenyls inhibit amyloid fibril formation.	+	-	nl	Chem Biol 11(12):1604-6 (2004) Van Vranken DL
40	2001	Transthyretin amyloidosis: a tale of weak interactions.	+	-	nl	FEBS Lett 498(2-3):201-3 (2001)
41	2002	Ideas of order for amyloid fibril structure.	+	-	nl	Structure 10(8):1031-6 (2002)
42	1997	Amyloid fibril formation and protein misassembly: a structural quest for insights into amyloid and prion diseases.	+	-	nl	Structure 5(5):595-600 (1997)
43	2004	The classification and typing of amyloid deposits.	+	-	nl	Am J Clin Pathol 121(6):787-9 (2004) Gertz MA
44	1998	The pathogenesis of amyloidosis: understanding general principles.	+	-	nl	Am J Pathol 152(5):1125-7 (1998)
45	1996	Leptomeningeal amyloid and variant transthyretins.	+	-	nl	Am J Pathol 148(2):351-4 (1996)
46	1996	Pulmonary amyloidosis. The Mayo Clinic experience from 1980 to 1993.	+	-	nl	Ann Intern Med 124(4):407-13 (1996)
47	1992	Reactive amyloidosis.	+	-	nl	Arch Dis Child 67(3):258-61 (1992)
48	2005	Transthyretin-related familial amyloidotic polyneuropathy.	+	-	nl	Arch Neurol 62(7):1057-62 (2005) Ando Y
49	1999	Long-term survival (10 years or more) in 30 patients with primary amyloidosis.	+	-	nl	Blood 93(3):1062-6 (1999)
50	1990	Amyloidosis: a final common pathway for protein deposition in tissues.	+	-	nl	Blood 75(3):531-45 (1990)
51	1976	Editorial: Newer concepts in amyloidogenesis.	+	-	nl	Can Med Assoc J 114(10):872-3 (1976)
52	1961	Renal amyloidosis: a review of 12 cases.	+	-	nl	Can Med Assoc J 85(-):967-73 (1961)
53	2005	Diagnosis and management of the cardiac amyloidoses.	+	-	nl	Circulation 112(13):2047-60 (2005) Falk RH
54	2006	Light-chain (AL) amyloidosis: diagnosis and treatment.	+	-	nl	Clin J Am Soc Nephrol 1(6):1331-41 (2006) Sanchorawala V
55	2009	Current treatment of AL amyloidosis.	+	-	nl	Haematologica 94(8):1044-8 (2009) Palladini G
56	2004	Cardiac amyloidosis: heterogenous pathogenic backgrounds.	+	-	nl	Intern Med 43(12):1107-14 (2004) Ikeda S
57	2006	Amyloidosis-associated kidney disease.	+	-	nl	J Am Soc Nephrol 17(12):3458-71 (2006) Dember LM
58	2004	Islet amyloid: a critical entity in the pathogenesis of type 2 diabetes.	+	-	nl	J Clin Endocrinol Metab 89(8):3629-43 (2004) Hull RL
59	2005	Amyloid in the cardiovascular system: a review.	+	-	nl	J Clin Pathol 58(2):125-33 (2005) Kholova I
60	1956	Primary amyloidosis: a review.	+	-	nl	J Clin Pathol 9(3):187-211 (1956)
61	1991	Inherited amyloidosis.	+	-	nl	J Med Genet 28(2):73-8 (1991)
62	1975	Genetic factors in amyloidosis.	+	-	nl	J Med Genet 12(4):317-26 (1975)
63	2002	Diagnosing primary amyloidosis.	+	-	nl	Mayo Clin Proc 77(12):1278-9 (2002) Gertz MA
64	2001	Amyloidosis.	+	-	nl	Postgrad Med J 77(913):686-93 (2001)
65	1987	Cerebral amyloid angiopathy. A critical review.	+	-	nl	Stroke 18(2):311-24 (1987)
66	1987	Cerebral amyloid angiopathy presenting as a mass lesion.	+	-	nl	Stroke 18(1):234-9 (1987)
67	2003	Molecular determinants for amyloid fibril formation: lessons from lung surfactant protein C.	+	-	nl	Swiss Med Wkly 133(19-20):275-82 (2003) Johansson J
68	2005	Amyloid heart disease. New frontiers and insights in pathophysiology, diagnosis, and management.	+	-	nl	Tex Heart Inst J 32(2):178-84 (2005) Hassan W
69	1983	Amyloid and the lower respiratory tract.	+	-	nl	Thorax 38(2):84-7 (1983)
70	2007	Evaluation and management of the cardiac amyloidosis.	+	-	nl	J Am Coll Cardiol 50(22):2101-10 (2007) Selvanayagam JB
71	2005	Dialysis-related amyloidosis revisited.	+	-	nl	AJR Am J Roentgenol 185(6):1460-7 (2005) Kiss E
72	2008	Use of eINDs for evaluation of multiple related PET amyloid plaque imaging agents.	+	-	nl	J Nucl Med 49(6):47N-48N (2008) Skovronsky D
73	1993	Uptake of technetium-99m MDP in primary amyloidosis with a review of the mechanisms of soft tissue localization of bone seeking radiopharmaceuticals.	+	-	nl	J Nucl Med 34(9):1612-5 (1993)
74	2004	[BIG-H3 protein: mutation of codon 124 and corneal amyloidosis].	+	-	nl	J Fr Ophtalmol 27(5):510-22 (2004) Schmitt-Bernard CF
75	2004	Amyloidosis: review and CT manifestations.	+	-	nl	Radiographics 24(2):405-16 (2004) Georgiades CS
76	1993	CT evaluation of amyloidosis: spectrum of disease.	+	-	nl	Radiographics 13(6):1295-308 (1993)
77	2009	MRI assessment of cardiac amyloidosis: experience of six cases with review of the current literature.	+	-	nl	Br J Radiol 82(976):337-42 (2009)
78	2010	Structure-based design of kinetic stabilizers that ameliorate the transthyretin amyloidoses.	+	-	nl	Curr Opin Struct Biol 20(1):54-62 (2010)
79	2010	Principles governing oligomer formation in amyloidogenic peptides.	+	-	nl	Curr Opin Struct Biol 20(2):187-95 (2010)
80	2010	Molecular mechanism of Thioflavin-T binding to amyloid fibrils.	+	-	nl	Biochim Biophys Acta 1804(7):1405-12 (2010)
81	2008	Patterns of neuropathy and autonomic failure in patients with amyloidosis.	+	-	nl	Mayo Clin Proc 83(11):1226-30 (2008)
82	2009	Modern treatment of amyloidosis: unresolved questions.	+	-	nl	J Am Soc Nephrol 20(3):469-72 (2009)
83	2011	Recent insights into the pathogenesis of type AA amyloidosis.	+	-	nl	ScientificWorldJournal 11(-):641-50 (2011)
84	2009	How I treat amyloidosis.	+	-	nl	Blood 114(15):3147-57 (2009)
85	2007	Bortezomib in the treatment of AL amyloidosis: targeted therapy?	+	-	nl	Haematologica 92(10):1302-7 (2007)
86	2010	Systemic light-chain amyloidosis: advances in diagnosis, prognosis, and therapy.	+	-	nl	Hematology Am Soc Hematol Educ Program 2010(-):287-94 (2010)
87	2008	Amyloid beta-degrading cryptidases: insulin degrading enzyme, presequence peptidase, and neprilysin.	+	-	nl	Cell Mol Life Sci 65(16):2574-85 (2008)
88	2010	Beta arcades: recurring motifs in naturally occurring and disease-related amyloid fibrils.	+	-	nl	FASEB J 24(5):1311-9 (2010)
89	2007	CD36: implications in cardiovascular disease.	+	-	nl	Int J Biochem Cell Biol 39(11):2012-30 (2007)
90	2009	Animal models of human amyloidoses: are transgenic mice worth the time and trouble?	+	-	nl	FEBS Lett 583(16):2663-73 (2009)
91	2006	Cardiac nonamyloidotic immunoglobulin deposition disease.	+	-	nl	Mod Pathol 19(2):233-7 (2006)
92	2009	Effect of nanoparticles on protein folding and fibrillogenesis.	+	-	nl	Int J Mol Sci 10(2):646-55 (2009)
93	2010	Transthyretin-related familial amyloidotic polyneuropathy-Progress in Kumamoto, Japan (1967-2010)-.	+	-	nl	Proc Jpn Acad Ser B Phys Biol Sci 86(7):694-706 (2010)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.